🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

Novo Integrated Sciences appoints new president

EditorRachael Rajan
Published 02/16/2024, 02:41 PM
© Reuters.
NVOS
-

BELLEVUE, Wash. - Novo Integrated Sciences, Inc. (NASDAQ:NVOS), a company engaged in a multidisciplinary healthcare ecosystem, has announced the appointment of Mr. Robert Oliva as its new President.

Mr. Oliva brings over 35 years of experience in business development and manufacturing operations to the role. He will be succeeding Mr. Christopher David, who will continue in his position as the Chief Operating Officer and maintain his seat on the Board of Directors.

The company's CEO and Board Chairman, Robert Mattacchione commented, "The addition of Mr. Oliva comes at a time when the Company is focusing significant energy and resources in ramping up our manufacturing and product offerings. His years of building a manufacturing business, from the ground up, into a significant, profitable enterprise will be an enormous asset in providing oversight and guidance to the Company's leadership team."

Novo Integrated Sciences is known for its holistic approach to healthcare, integrating medical technology, advanced therapeutics, and rehabilitative science to provide patient-first health and wellness services.

The company's approach to decentralizing healthcare aims to shift non-critical care from primary medical centers to patients' homes, leveraging advancements in medical technology and interconnectivity. This model is intended to prevent the escalation of non-critical health conditions and provide more cost-effective healthcare distribution.

The information in this article is based on a press release statement from Novo Integrated Sciences.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.